TP53 and lung carcinoma: In addition to lowering blood glucose, anti-mutation, and eliminating free radicals in the body, myricetin also has anticancer potential, which prevents cell cycle progression in A549 lung cancer cells, enhances p53 expression and ROS-dependent mitochondria-mediated death, showing certain cytotoxicity (27).